Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Chai, Yin-Hea | Han, Yi-Penga | Zhang, Jin-Yana | Zhou, Jian-Bob; *
Affiliations: [a] Beijing Tongren Hospital, Capital Medical University, Beijing, China | [b] Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China
Correspondence: [*] Correspondence to: Jian-Bo Zhou, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, China. E-mail: jbzhou@ccmu.edu.cn.
Abstract: Background:Accumulating evidence has demonstrated that hyperglycemia is a possible risk factor for mild cognitive impairment or Alzheimer’s disease. Diabetic retinopathy (DR) has been identified as a risk factor for dementia in patients with diabetes. Objective:This study aimed to investigate the causal relationships between DR and brain structure, cognitive function, and dementia. Methods:We performed bidirectional two-sample Mendelian randomization for DR, brain structure, cognitive function, and dementia using the inverse-variance weighted method. Results:Inverse-variance weighted analysis showed the association of DR with vascular dementia (OR = 1.68, 95% CI: 1.01–2.82), and dementia was significantly associated with the increased risk of non-proliferative DR (NPDR) (OR = 1.76, 95% CI: 1.04–2.98). Furthermore, better cognitive performance was significantly associated with a reduced risk of NPDR (OR = 0.85, 95% CI: 0.74–0.98). No association was observed between DR and brain structure. Conclusions:These findings suggest that the association of DR with vascular dementia. The reciprocal effect of cognitive performance and dementia on NPDR risk highlights the potential benefits of dementia prevention for reducing the burden of DR.
Keywords: Alzheimer’s disease, cerebral cortex, cognitive function, dementia, diabetic retinopathy, Mendelian randomization, vascular dementia
DOI: 10.3233/JAD-231022
Journal: Journal of Alzheimer's Disease, vol. 97, no. 3, pp. 1211-1221, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl